COMBINATION TREATMENT OF THE NOVEL PHARMACOLOGICAL FXR-COMPOUND PX20606 AND EZETIMIBE LEADS TO MASSIVELY INCREASED NEUTRAL STEROLS EXCRETION IN MICE

M. Schonewille; J. F. de Boer; M. Boesjes; H. Wolters; H. Verkade; U. Tietge; C. Kremoser; A. K. Groen

COMBINATION TREATMENT OF THE NOVEL PHARMACOLOGICAL FXR-COMPOUND PX20606 AND EZETIMIBE LEADS TO MASSIVELY INCREASED NEUTRAL STEROLS EXCRETION IN MICE

M. Schonewille, J. F. de Boer, M. Boesjes, H. Wolters, H. Verkade, U. Tietge, C. Kremoser, A. K. Groen

Center for Liver, Digestive and Metabolic Diseases (CLDM)

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Pages (from-to)	E184-E184
Number of pages	1
Journal	Atherosclerosis
Volume	235
Issue number	2
Publication status	Published - Aug-2014
Event	82nd Congress of the European-Atherosclerosis-Society (EAS) - Madrid, Spain Duration: 31-May-2014 → 3-Jun-2014

Access to Document

http://apps.webofknowledge.com/Search.do?product=WOS&SID=W1Jdutb5Kiz6UdSj4ks&search_mode=GeneralSearch&prID=3d8306d5-757c-4a2e-a359-a7629ffb9edc

Handle.net

Persistent link

Cite this

Schonewille, M., de Boer, J. F., Boesjes, M., Wolters, H., Verkade, H., Tietge, U., Kremoser, C., & Groen, A. K. (2014). COMBINATION TREATMENT OF THE NOVEL PHARMACOLOGICAL FXR-COMPOUND PX20606 AND EZETIMIBE LEADS TO MASSIVELY INCREASED NEUTRAL STEROLS EXCRETION IN MICE. Atherosclerosis, 235(2), E184-E184. http://apps.webofknowledge.com/Search.do?product=WOS&SID=W1Jdutb5Kiz6UdSj4ks&search_mode=GeneralSearch&prID=3d8306d5-757c-4a2e-a359-a7629ffb9edc

@article{fddea3233d35493d94ed604e0b133afb,

title = "COMBINATION TREATMENT OF THE NOVEL PHARMACOLOGICAL FXR-COMPOUND PX20606 AND EZETIMIBE LEADS TO MASSIVELY INCREASED NEUTRAL STEROLS EXCRETION IN MICE",

author = "M. Schonewille and {de Boer}, {J. F.} and M. Boesjes and H. Wolters and H. Verkade and U. Tietge and C. Kremoser and Groen, {A. K.}",

year = "2014",

month = aug,

language = "English",

volume = "235",

pages = "E184--E184",

journal = "Atherosclerosis",

issn = "0021-9150",

publisher = "ELSEVIER IRELAND LTD",

number = "2",

note = "82nd Congress of the European-Atherosclerosis-Society (EAS) ; Conference date: 31-05-2014 Through 03-06-2014",

}

Schonewille, M, de Boer, JF, Boesjes, M, Wolters, H, Verkade, H, Tietge, U, Kremoser, C & Groen, AK 2014, 'COMBINATION TREATMENT OF THE NOVEL PHARMACOLOGICAL FXR-COMPOUND PX20606 AND EZETIMIBE LEADS TO MASSIVELY INCREASED NEUTRAL STEROLS EXCRETION IN MICE', Atherosclerosis, vol. 235, no. 2, pp. E184-E184. <http://apps.webofknowledge.com/Search.do?product=WOS&SID=W1Jdutb5Kiz6UdSj4ks&search_mode=GeneralSearch&prID=3d8306d5-757c-4a2e-a359-a7629ffb9edc >

TY - JOUR

T1 - COMBINATION TREATMENT OF THE NOVEL PHARMACOLOGICAL FXR-COMPOUND PX20606 AND EZETIMIBE LEADS TO MASSIVELY INCREASED NEUTRAL STEROLS EXCRETION IN MICE

AU - Schonewille, M.

AU - de Boer, J. F.

AU - Boesjes, M.

AU - Wolters, H.

AU - Verkade, H.

AU - Tietge, U.

AU - Kremoser, C.

AU - Groen, A. K.

PY - 2014/8

Y1 - 2014/8

M3 - Meeting Abstract

SN - 0021-9150

VL - 235

SP - E184-E184

JO - Atherosclerosis

JF - Atherosclerosis

IS - 2

T2 - 82nd Congress of the European-Atherosclerosis-Society (EAS)

Y2 - 31 May 2014 through 3 June 2014

ER -